Pacer Advisors, Inc. Rigel Pharmaceuticals Inc Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$3.09 - $4.54 $45,237 - $66,465	-14,640 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$3.35 - $4.93 $6,659 - $9,800	1,988 Added 15.71%	14,640 $50,000
Q4 2020 Jan 20, 2021	BUY	$2.35 - $3.74 $29,732 - $47,318	12,652 New	12,652 $44,000
Q4 2018 Feb 13, 2019	SELL	$2.08 - $3.36 $40,008 - $64,629	-19,235 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $50,011 - $69,053	19,235 New	19,235 $62,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.